Please login to the form below

Not currently logged in
Email:
Password:

Questcor Pharmaceuticals

This page shows the latest Questcor Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

This includes the $5.6bn deal for Questcor Pharmaceuticals last year and its purchase of Cadence Pharmaceuticals for $1.3bn.

Latest news

  • Mallinckrodt cuts $5.6bn deal to buy Questcor Mallinckrodt cuts $5.6bn deal to buy Questcor

    Mallinckrodt cuts $5.6bn deal to buy Questcor. Irish company continues move from medical imaging to pharma products. ... the balance of its portfolio away from medical imaging and into specialty pharmaceuticals.

  • Scott Whitcup joins Questcor’s board of directors

    Scott Whitcup, executive VP of R&D and chief scientific officer at Amgen, has joined the board of directors at Questcor Pharmaceuticals. ... The growth strategies and product manufacturing for Acthar and Botox have some interesting parallels,” said

  • Questcor MS drug wins new indication

    Questcor MS drug wins new indication. Questcor Pharmaceuticals has won US Food and Drug Administration approval of a new indication for its for HP Acthar Gel. ... Questcor Pharmaceuticals, which specialises in drugs for difficult-to-treat diseases, has

  • The Pump House

    Hepatitis. China. Mecasermin rinfabate. Iplex (Insmed). Growth disorders. US. Methylphenidate. Methylin Chewable Tablets (Alliant Pharmaceuticals). ... Quazepam. (Questcor Pharmaceuticals). Insomnia. US. Risperidone. Generic risperidone (Actavis Group).

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    All told 24% of its revenues will come from in consumer health, 62% pharmaceuticals and 14% vaccines. ... Having purchased Cadence Pharmaceuticals for $1.4bn in February of this year (Ofirmev, an iv injectable acetaminophen for pain), April saw the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Questcor appoints SVP corporate strategic development Questcor appoints SVP corporate strategic development

    US biopharma Questcor Pharmaceuticals has named Michael Aldridge as its first senior VP, corporate strategic development. ... Development programmes that complement Acthar are also a potential as Questcor looks to expand.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics